Virtual Medicinal Product (VMP)
-
Galantamine 8mg modified-release capsules
Name Details
Current Name
Galantamine 8mg modified-release capsules
|
Start Date
01-06-2005
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- capsule
- Unit Dose UOM
- capsule
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Modified-release capsule
- Ontology Form/Route
- capsulemodified-release.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
N06DA04
BNF |
Current BNF
04110000
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
04110000
|
Start Date
03-11-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
9306011000001105 |
01-06-2005 |
|
VMP Ingredients
Name
Galantamine hydrobromide
Basis of strength description
Based on Base Substance
BOSS
Galantamine
Strength and UOM (Nmr)
8
Strength and UOM (Dmr)
Parent Products
-
VTM
Galantamine
-
VMP
(Current) Galantamine 8mg modified-release cap...
Virtual Medicinal Product Pack (VMPP) Information